Boston Scientific (NYSE:BSX) Price Target Lowered to $90.00 at Stifel Nicolaus
Boston Scientific (NYSE:BSX – Get Free Report) had its price objective cut by stock analysts at Stifel Nicolaus from $110.00 to $90.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the medical equipment provider’s stock. Stifel Nicolaus’ price objective would suggest a potential upside of 28.61% […]
20 Mar 16:38 · The Markets Daily